Private alpha · 5 seats remaining

Find the right life sciences accounts

and the signal that makes them ready now.

Pistachio helps life sciences BD and commercial teams identify who to target, when to reach out, and why now — using what's actually changing inside companies.

Live

Priority Stakeholders

Surfaced from 1,200+ signals across your target market
AstraZeneca

David Lam

VP Data Science · AstraZeneca

94fit
Signals detected
Confirmed attending Bio-IT World
5 publications on ML in drug discovery
2 posts on AI workflows this month
Why now

His team is actively scaling ML infrastructure for molecular representations — exactly the problem your platform solves.

Suggested opener

"Saw your post on scaling molecular representations — we've been working with teams hitting similar limits. Compare notes at Bio-IT?"

LinkedIn post 3 days ago
Saved2.5hofdaily linkedin monitoring
Roche

Sarah Chen

Head of Computational Bio · Roche

89fit
Signals detected
Team hiring 5 roles in AI/ML
She leads the team they're building
Spoke at AACR on target ID
Why now

Teams scaling up AI/ML often need external platforms to accelerate — your timing is perfect as she builds.

Suggested opener

"Noticed your team is scaling up AI/ML — happy to share what's worked for similar buildouts. Free for coffee at Bio-IT?"

Job posting 2 days ago
Saved3hofweekly careers page checks
Novartis

Michael Torres

Dir. External Innovation · Novartis

91fit
Signals detected
Hosting AI in Pharma Partnerships panel
3 deals closed in 2025 with AI biotechs
Actively scouting AI platforms
Why now

He's the decision-maker for AI partnerships and has a track record of closing deals with companies like yours.

Suggested opener

"Looking forward to your panel — we've helped accelerate a few AI partnerships in this space. Would love to connect after."

Panel announced last week
Saved4hofconference agenda tracking

9.5 hours of research saved on this page alone —signals updated in real-time

Updated 2 hours ago · 34 more stakeholders available
The workflow

How teams use Pistachio

Right Time

Right Account

Right Stakeholder

Right Messaging

1

Narrow the market to accounts that matter

The problem: As an early team, everyone could be a customer — which means no one is a priority.

Pistachio: Helps startups narrow a broad pharma and biotech landscape into a focused list of accounts most likely to be receptive right now, based on real activity.

2

Understand why an account would care today

The problem: Cold outreach sounds generic because timing is unclear.

Pistachio: For each prioritized account, provides clear context on what has changed recently — giving founders a concrete reason to reach out now.

3

Focus on stakeholders who own the problem

The problem: Reaching the wrong team wastes your best early shots.

Pistachio: Connects account activity to the teams and roles most likely to feel the pain, helping focus on stakeholders who can evaluate and champion a new product.

4

Reach out with relevance — not a generic pitch

The problem: Early outreach feels risky when every message is a guess.

Pistachio: With account focus, timing context, and stakeholder clarity, teams can reach out with messages that feel informed and relevant — increasing reply rates.

PRIVATE ALPHA

Don't sell to job titles.
Sell to the science.

Join the alpha. Only 5 seats remaining.